PlumX Metrics
Embed PlumX Metrics

Current Strategies and Future Perspectives for Intraperitoneal Adhesion Prevention

Journal of Gastrointestinal Surgery, ISSN: 1091-255X, Vol: 16, Issue: 6, Page: 1256-1274
2012
  • 128
    Citations
  • 0
    Usage
  • 111
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    128
  • Captures
    111
  • Mentions
    1
    • News Mentions
      1
      • 1

Most Recent News

Efficacy and Dose Ranging Study of Seroguard

STUDY INFORMATION OFFICIAL TITLE: Phase II Multi-center Randomized Double-blind Placebo-controlled Efficacy and Dose Ranging Trial of the Drug Product Seroguard, Solution (JSC Pharmasyntez, Russia) Used

Review Description

The formation of peritoneal adhesions still is a relevant clinical problem after abdominal surgery. Until today, the most important clinical strategies for adhesion prevention are accurate surgical technique and the physical separation of traumatized serosal areas. Despite a variety of barriers which are available in clinical use, the optimal material has not yet been found. Mesothelial cells play a crucial physiological role in frictionless gliding of the serosa and the maintenance of an antiadhesive surface. The formation of postoperative adhesions results from a cascade of events and is regulated by various cellular and humoral factors. Therefore, optimization or functionalization of barrier materials by developments interacting with this cascade on a structural or pharmacological level could give an innovative input for future strategies in peritoneal adhesion prevention. For this purpose, the proper understanding of the formal pathogenesis of adhesion formation is essential. Based on the physiology of the serosa and the pathophysiology of adhesion formation, the available barriers in current clinical practice as well as new innovations are discussed in the present review.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know